People compare these two because both are 'diabetes drugs' — but they do almost nothing in common. Metformin lowers liver glucose output and is weight-neutral to mildly weight-losing. Ozempic presses appetite and slows digestion. If your goal includes weight loss, the food rules that matter are the Ozempic ones.
| A | B | |
|---|---|---|
| Class | Biguanide (pill) | GLP-1 (injection) |
| Mechanism | Reduces liver glucose output | Suppresses appetite, slows emptying |
| Weight effect | Mild loss or neutral | ~7-15% (diabetes trials) |
| GI side effects | Diarrhea, stomach upset | Nausea, constipation |
| Food rules | Largely unchanged | Protein-first, nausea-aware |
The same judgment framework runs across this site — protein, fiber and how heavy a food sits on a slow stomach.
| Easy on both | Risky on both |
|---|---|
|
|
Yes — that is a common combination for type 2 diabetes. The metformin is typically dosed with meals, and the Ozempic food rules (protein, small meals) apply on top.
Ozempic, generally. Metformin's GI effects are mostly early-diarrhea and stomach upset; Ozempic's nausea comes from slowed stomach emptying and is food-dependent.
No. Metformin does not suppress appetite, so the protein-first, small-meal framework is not required the way it is on a GLP-1.
This comparison presents published trial data (STEP, SURMOUNT, SCALE, OASIS 4) and FDA label information for reference. It is not medical advice and does not recommend any medication. Prescription decisions belong to you and your healthcare provider.